Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:46:24 EDT Fri 13 Jun 2025
Enter Symbol
or Name
USA
CA



Q:NEO - NEOGENOMICS INC - https://www.neogenomics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NEO - Q0.16.75·8.350.17.39-0.44-5.62,915.421,01712,7777.73  7.73  7.3619.115  6.0817:44:31May 2815 min RT 2¢

Recent Trades - Last 10 of 12777
Time ETExPriceChangeVolume
17:44:31Q7.71-0.125
17:40:06Q7.39-0.44490,900
16:50:07Q7.38-0.45520
16:49:06Q7.385-0.4451
16:48:25Q7.39-0.441
16:30:51Q7.30-0.53144
16:04:14Q7.39-0.441
16:04:14Q7.39-0.441
16:04:09Q7.39-0.441
16:04:08Q7.39-0.441

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-28 07:10U:NEONews ReleaseNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
2025-05-22 07:10U:NEONews ReleaseNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
2025-05-20 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming June Investor Conferences
2025-05-01 07:05U:NEONews ReleaseNeoGenomics Pays Off 1.25% Convertible Senior Notes
2025-04-29 08:00U:NEONews ReleaseNeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
2025-04-29 07:30U:NEONews ReleaseNeoGenomics Reports First Quarter 2025 Results
2025-04-22 07:05U:NEONews ReleaseNeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
2025-04-08 07:05U:NEONews ReleaseNeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
2025-04-07 07:05U:NEONews ReleaseNeoGenomics Completes Acquisition of Pathline
2025-04-01 07:05U:NEONews ReleaseTony Zook Assumes Role as Chief Executive Officer of NeoGenomics
2025-03-18 07:05U:NEONews ReleaseNeoGenomics Appoints Warren Stone as President & Chief Operating Officer
2025-03-10 07:00U:NEONews ReleaseNeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
2025-02-24 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2025-02-18 07:05U:NEONews ReleaseNeoGenomics Reports Fourth Quarter and Full Year 2024 Results
2025-01-30 09:05U:NEONews ReleasePacBio Announces Appointment of Chris Smith to Board of Directors
2025-01-29 08:05U:NEONews ReleaseNeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
2025-01-15 07:05U:NEONews ReleaseNeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
2025-01-14 07:30U:NEONews ReleaseAdaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
2025-01-10 07:05U:NEONews ReleaseNeoGenomics Announces Chief Executive Officer Succession
2025-01-06 07:55U:NEONews ReleaseNeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference